Pharem, a Greentech frontrunner in enzyme-based water treatment solutions, has joined forces with the global biopharmaceutical company AstraZeneca to develop sustainable water treatment solutions. Using Pharem's platform Zymatic, the companies target one or several waste streams from API manufacturing to find new ways of treatment using enzymes.
Pharem Biotech and Leading Cities (AcceliGOV) is now accepting applications from any wastewater treatment plant or industrial water processor. The application is open until mid-March for a funded water treatment pilot. The pilot is worth $100,000 targeting organic micropollutants and unwanted organic compounds to reduce chemical emissions to our water environments
Pharem have successfully increased their portfolio of customer related projects, both in the Nordic countries but also internationally. To accelerate these projects Pharem have been granted financing from Nefco.
